Merck & Company, Inc. vs Organigram Global Inc. — Stock Comparison
Merck & Company, Inc. (MRK) and Organigram Global Inc. (OGI) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Organigram Global Inc. narrowly edges Merck & Company, Inc. on Q·Score (6.9 vs 6.4 out of 10), led by Quality (7.8 vs 4.9) and Health (8.1 vs 7). Merck & Company, Inc. scores higher on Valuation, reflecting stronger P/E and price-target positioning. Analysts covering MRK have a consensus price target implying +5.6% from current levels.
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
71% of 28 covering analysts have a positive rating.
⚠ weak profitability metrics drag quality score.
Clean balance sheet with low leverage (0.1× debt-to-equity).
⚠ valuation metrics above sector average.
Analyst Consensus
Fundamentals
Frequently Asked Questions
MRK vs OGI: which stock scores better overall?
Based on Q·Score, Organigram Global Inc. (OGI) scores 6.9/10 versus Merck & Company, Inc. (MRK) at 6.4/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: MRK or OGI?
Merck & Company, Inc. (MRK) scores higher on Growth (6.4/10 vs 6/10). Merck & Company, Inc. reports revenue growth (5.1% YoY) while Organigram Global Inc. reports (49.4% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is MRK or OGI more attractively valued?
Merck & Company, Inc. (MRK) scores higher on Valuation (7/10 vs 5/10). MRK trades at 15.2× P/E versus OGI at 48.2×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about MRK vs OGI?
There are 26 analysts covering MRK with a consensus price target of $152.96, and OGI with a consensus target of N/A. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: MRK or OGI?
Organigram Global Inc. (OGI) scores higher on Quality (7.8/10 vs 4.9/10). Net profit margin: MRK at 4.8%, OGI at 28.0%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: MRK or OGI?
Organigram Global Inc. (OGI) scores higher on Financial Health (8.1/10 vs 7/10). Market beta: MRK at 0.23, OGI at 1.91. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of MRK and OGI?
Merck & Company, Inc. (MRK) has a market capitalisation of $357.5B, while Organigram Global Inc. (OGI) has a market cap of $153M. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do MRK or OGI pay dividends?
MRK pays a dividend yield of 2.36%, while OGI does not currently pay a dividend. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →